IVF financial statements and SEC filings

IVF annual income statement

Fiscal period endRevenueOperating incomeNet incomeSEC filing
2025-12-31$6.84M-$7.24M-$25.13M10-K
2024-12-31$6.53M-$6.63M-$9.51M10-K
2023-12-31$3.02M-$6.77M-$8.03M10-K
2022-12-31$822.20K-$10.63M-$10.89M10-K/A
2021-12-31$4.16M-$5.22M-$6.65M10-K
2020-12-31$1.04M-$5.51M-$8.35M10-K

IVF annual balance sheet

Fiscal period endAssetsLiabilitiesEquitySEC filing
2025-12-31$20.22M$13.00M$7.22M10-Q
2024-12-31$46.08M$26.04M$12.58M10-K
2023-12-31$18.51M$17.61M$892.83K10-K
2022-12-31$3.71M$4.69M-$977.61K10-K/A
2021-12-31$10.47M$3.16M$7.31M10-K
2020-12-31$10.95M$5.20M$5.74M10-K

IVF annual cash flow

Fiscal period endOperating cash flowCapital expenditureFinancing cash flowSEC filing
2025-12-31-$7.01M-$43.41K$11.10M10-K
2024-12-31-$2.97M-$183.70K$3.12M10-K
2023-12-31-$4.76M-$444.72K$7.39M10-K
2022-12-31-$6.60M-$10.79K$1.09M10-K/A
2021-12-31-$6.03M-$415.71K$3.77M10-K
2020-12-31-$4.78M-$49.26K$13.82M10-K